Clinical trial
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
NCT00096356 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 27, 2004
- Completion date
- August 31, 2009
- Enrollment
- 236 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, fatigue